In this study, we demonstrated that systemic IgG levels against the pertussis vaccine antigens PT, FHA, and Prn persisted at higher levels for at least 2 years after a first adult aP booster vaccination in young Dutch adults 25–29 years of age, who had been primed in infancy with whole-cell pertussis vaccine. The gene discussed is CIAO3; the disease is pertussis.